Robert E Bristow

Dr. Robert E. Bristow is a Professor and Chair of Obstetrics & Gynecology at the University of California, Irvine (UCI) School of Medicine, holding the Philip J. DiSaia Chair in Gynecologic Oncology. His research focuses on improving early detection of ovarian cancer through multivariate index assays (MIA), comparative analysis with CA 125-II and ACOG guidelines, and developing clinical tools for adnexal mass evaluation. His work spans biomarker validation, proteomics, and clinical decision-making frameworks in gynecologic oncology.

Key research contributions include validating MIA's superior sensitivity (95.3%) for early-stage ovarian malignancy compared to traditional methods, with consistent performance across menopausal status. Clinical trials involving 44 sites demonstrated MIA's enhanced diagnostic accuracy in premenopausal (89.3% sensitivity) and postmenopausal patients (98.3% sensitivity). Collaborative studies explore metabolomic and proteomic signatures for tumor differentiation, while economic evaluations highlight MIA's cost-effectiveness relative to CA 125.

Dr. Bristow's publications emphasize translational research bridging biomarker discovery (e.g., serum proteins, plasma metabolites) and clinical implementation for ovarian cancer risk stratification. He has contributed to national guidelines and comparative effectiveness research, though no specific awards or student mentorship details were found in the provided texts.